Morgan Lewis

Related Publications

05/02/12 Update on the Biosimilars Competition and Innovation Act: Overview and Life Cycle Planning for Biosimilars, presented at the BioNJ Diamond Circle Board of Trustees Meeting
(pdf)
04/02/12 It’s Not Just Pill Mills The DEA Is After, Law360
(pdf)
03/09/12 Pharmacies and Suppliers Beware: It Is Not Just the Pill Mills They Are After
DEA's recent position against a national pharmacy chain and a wholesale distributor expands the proactive monitoring and auditing requirements for pharmacies and wholesale distributors to include site visits and possibly medical necessity reviews.
View all publications

Related News

04/09/12 Morgan Lewis Advises Sun Capital on Acquisition of CornerStone
Morgan Lewis served as legal advisor to Sun Capital on its affiliate's acquisition of CornerStone Research & Development, Inc., from Mitsui & Co., Inc.
05/28/10 Attorneys See Uncertainty in FDA's Implementation of Biosimilar Approvals, Life Sciences Law & Industry Report
09/24/09 Morgan Lewis Advises LEO Pharma on $1 Billion Acquisition
Morgan Lewis represented LEO Pharma in the $1 billion acquisition of exclusive product licensing rights and inventories from LEO Pharma by Warner Chilcott plc.
View all news
Your message will be sent to: Kathleen M. Sanzo